Cargando…

MicroRNA-623 inhibits tumor progression and is a predictor of poor prognosis of breast cancer

Dysregulated microRNAs (miRNAs) serve vital roles in the progression and prognosis of breast cancer. miR-623 has been reported to influence the progression of numerous other cancers, such as lung adenocarcinoma and hepatocellular carcinoma, however, its role in breast cancer remains unclear. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chunfeng, Wang, Juan, Zhang, Jing, Li, Yongxiang, Sun, Qinghui, Guo, Feng, An, Xiupeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656110/ https://www.ncbi.nlm.nih.gov/pubmed/33193846 http://dx.doi.org/10.3892/ol.2020.12249

Ejemplares similares

MicroRNA-623 Inhibits Epithelial–Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44
por: Cui, Dawei, et al.
Publicado: (2020)

High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer
por: Sim, Jongmin, et al.
Publicado: (2015)

MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer
por: Jiang, Lihua, et al.
Publicado: (2018)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2016)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017)

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
por: Huang, Wei, et al.
Publicado: (2020)

Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020)

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer
por: Shen, Shu-na, et al.
Publicado: (2013)

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2018)

MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma
por: Tang, Mingjie, et al.
Publicado: (2013)

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2019)

MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer
por: Chen, Yutong, et al.
Publicado: (2019)

SAT623 Everolimus For Treatment-refractory Prolactinomas
por: Lin, Andrew L, et al.
Publicado: (2023)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme
por: Cheray, Mathilde, et al.
Publicado: (2020)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
por: Wang, Yongxia, et al.
Publicado: (2018)

Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
por: Jiang, Wei, et al.
Publicado: (2017)

Prediction of Poor Prognosis in Breast Cancer Patients Based on MicroRNA-21 Expression: A Meta-Analysis
por: Wang, Yanyan, et al.
Publicado: (2015)

MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
por: Zhao, Lin, et al.
Publicado: (2016)

623. Advancing Fungal Diagnostics with a Transcriptional Approach
por: Young, Eleanor, et al.
Publicado: (2023)

MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer
por: Liu, Huiya, et al.
Publicado: (2019)

miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer
por: Li, Qing, et al.
Publicado: (2020)

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
por: Lu, Shengkui, et al.
Publicado: (2012)

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer
por: Dong, Menglu, et al.
Publicado: (2021)

High expression of microRNA 221 is a poor predictor for glioma
por: Song, Yanlin, et al.
Publicado: (2020)

MicroRNA-183 and microRNA-141 are potential risk factors for poor prognosis in patients with nasopharyngeal carcinoma
por: Lian, Junsheng, et al.
Publicado: (2019)

The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
por: Gonzalez-Perez, Abel, et al.
Publicado: (2013)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

The Experiences in a Toxicology Unit: A Review of 623 Cases
por: Koylu, Ramazan, et al.
Publicado: (2014)

623. Dynamic Nature of the Gut Resistome Among Infants in Singapore
por: Zain, Amanda, et al.
Publicado: (2018)

623 Multi-Modal Analgesia for > 10% TBSA Pediatric Burns
por: Wratney, Angela, et al.
Publicado: (2022)

Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Kuang-Tzu, et al.
Publicado: (2017)

High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
por: Wang, Wen-yao, et al.
Publicado: (2014)

microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer
por: Chen, Dong-liang, et al.
Publicado: (2015)

Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
por: Zeng, Zhihao, et al.
Publicado: (2017)

Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma
por: Song, Qian, et al.
Publicado: (2019)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9h4kr8vfai8i6r4gfga18b39jp